Clinical Trial Update: Improving Cognitive Health in COVID-19 Survivors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cognitive health interventions in COVID-19 survivors has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Dysfunction

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Cognitive Dysfunction, Covid19 | Phase 2 | Status: COMPLETED | Results posted: 2024-02-29